Focal expression of thymidine phosphorylaze associates with CD31 positive lymphocytic aggregation and local neo-angiogenesis in non-small cell lung cancer

Anticancer Research

Volumn 18, Issue 1 A, 1998, Pages 71-76

  Giatromanolaki, Alexandra ^a,c   Koukourakis, Michael I ^a,c   Kakolyris, Stelios ^a,c   Kaklamanis, Loukas ^c   Barbatis, Kalypso ^b   O'Byrne, Ken J ^c   Theodosssiou, Dimetrios ^a   Harris, Adrian L ^c   Gatter, Kevin C ^c  

^a UNIVERSITY HOSPITAL OF IRAKLION   (Greece)

^b RED CROSS HOSPITAL   (Greece)

^c OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Angiogenesis; Inflammatory component; Lung cancer; Platelet derived endothelial cell growth factor; Thymidine phosphorylaze

Indexed keywords

CD31 ANTIGEN; PLATELET DERIVED ENDOTHELIAL CELL GROWTH FACTOR; THYMIDINE PHOSPHORYLASE;

ANGIOGENESIS; ARTICLE; CANCER CELL; CANCER GRADING; CELL AGGREGATION; CELL INFILTRATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MICROVASCULATURE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTIGENS, CD31; CARCINOMA, NON-SMALL-CELL LUNG; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; HUMANS; IMMUNITY, CELLULAR; LUNG NEOPLASMS; LYMPHOCYTE SUBSETS; LYMPHOCYTES, TUMOR-INFILTRATING; NEOVASCULARIZATION, PATHOLOGIC; THYMIDINE PHOSPHORYLASE;

EID: 0031945961     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Miyazono K, Okabe T, Urabe A, Takaku F, Heldin CH: Purification and properties of an endothelial cell growth factor from human platelets. J Biol Chem 262: 4098-4103, 1987.
2. Ishikawa F, Miyazono K, Hellman U, Drexler H, Wernstedt C, Hagiwara K, Usuki K, Takaku F, Risau W, Heldin CH: Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor. Nature 338: 557-562, 1989.
3. Moghaddam A, Bicknell R: Expression of platelet-derived endothelial cell growth factor in Escherichia coli and confirmation of its thymidine phosphorylaze activity. Biochemistry 31: 12141-12146, 1992.
4. Usuki K, Saras J, Waltenberger J, Miyazono K, Pierce G, Thomason A, Heldin CH. Platelet-derived endothelial cell growth factor hasthymidinephosphorylazeactivity. Biochem Biophys Res Commun 184: 1311-1316, 1992.
5. Barton GJ, Ponting CP, Spraggon G, Finnis C, Sleep D: Human platelet-derived endothelial cell growth factor is homologous to Escherichia coli thymidine phosphorylaze. Protein Science 1: 688-690, 1992.
6. Haraguchi M, Kazutaka M, Uemura K, Sumizawa T, Furukawa T, Yamada K, Akiyama SI. Angiogenic activity of enzymes. Nature 368: 198, 1994.
7. Moghaddam A, Zhang HT, Fan TPD, Hu DE, Lees VC, Turley H, Fox SB, Gatter KC, Harris AL, Bicknell R: Thymidine phosphorylaze is angiogenic and promotes tumor growth. Proc Natl Acad Sci USA 92: 998-1002, 1995.
8. Giatromanolaki A, Koukourakis M, O'Byrne K, Fox S, Whitehouse R Talbot D, Harris AL, Gatter KC: Prognostic value of angiogenesis in operable non-small cell lung cancer. J Pathol 179: 80-88, 1996.
9. Koukourakis MI, Giatromanolaki A, O'Byrne K, Cornley M, Whitehouse R, Talbot DC, Gatter KC, Harris AL: Platelet-Derived Endothelial Cell Growth Factor expression correlates with tumour angiogenesis and prognosis in non-small cell lung cancer. Br J Cancer 4: 477-481, 1997.
10. Giatromanolaki A, Koukourakis M, Comley M, Kaklamanis L, Turley H, O'Byrne K, Harris AL, Gatter KC: Platelet- derived endothelial cell growth factor (thymidine phosphorylaze) expressionin lung cancer. J Pathol 181: 196-199, 1997.
11. Mountain CF: A new international staging system for lung cancer. Chest 89(Suppl): 225-233, 1986.
12. Fox SB, Moghaddam A, Westwood M, Turley H, Bicknell R Gatter KC, Harris AL: Platelet derived endothelial cell growth factor/thymidine phosphorylaze expression in normal tissues an irnmunohistochemical study. J Pathol 176: 183-190, 1995.
13. Parums DV, Cordell JL, Micklem K, Heryet AR, Gatter KC, Mason DY: JC70: a new monoclonal antibody that detects vascular endothelium associated antigen on routinely processed tissue sections. J Clin Pathol 43: 752-757, 1990.
14. ChaLkley H. Method for the quantative morphological analysis of tissues. J Natl Cancer Inst 4: 47-53, 1943.
15. Sotos GA, Grogan L, Allegra CJ. Preclinical and clinical aspects of biomodulation of 5-fluorouracil. Cancer Treatment Reviews 20: 11-49, 1994.
16. Toi M, Hoshina S, Taniguchi T, Yamamoto Y, Ishitsuka H, Tominaga T: Expression of platelet-derived endothelial cell growth factor/thymidine phospshorylase in human breast cancer. Int J Cancer 64: 79-82, 1995.
17. Fox SB, Westwood M, Moghaddam A, Compley M, Helen T, Whitehouse RM, Bicknell R Gatter KC, Harris AL: The angiogenic factor platelet derived endothelial cell growth factor/thymidine phosphorylaze is upregulated in breast cancer epithelium and endothelium. Br J Cancer 73: 275-280, 1996.
18. Takebayashi Y, Miyadera K, Akiyama S, Hokita S, Yamada K, Akiba S, Sumizawa T, Aikou T: Expression of thymidine phosphorylaze in human gastric carcinoma. Jpn J Cancer Res 87: 288-295, 1996.
19. Giatromanolaki A, Koukourakis M, O'Byrne K, Kaklamanis L, Dicoglou C, Trichia E, Whitehouse R, Harris AL, Gatter KC: Non small cell lung cancer: C-erbB-2 correlates with low angiogenesis and poor prognosis. Anticancer Res 16: 3819-3825, 1996.
20. Takahashi Y, Bucana CD, Liu W, Yoneda J, Kitadai Y, Cleary KR Ellis LM: Platelet-derived Endothelial cell growth factor in human colon cancer angiogenesis: role of infiltrating cells. J Natl Cancer Inst 88: 1146-1151, 1996.
21. Polverini PJ, Leibovich SJ: Induction of neovascularization in vivo and endothelial proliferation in vitro by tumour associated macrophages. Lab Invest 51: 635-642, 1984.
22. Leek RD, Lewis CE, Whitehouse R, Greenall M, Clarke J, Harris AL: Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res 56: 4625-4629, 1996.
23. Gruber BL, Marchese MJ, Kew R: Angiogenic factors stimulate mast-cell migration. Blood 86: 2488-2493, 1995.
24. Zocchi MR, Ferrero E, Leone BE, Rovere P, Bianchi E, Toninelli E, Pardi R: CD31/PECAM-1 driven chemokine-independent transmigration of human T- lymphocytes. Eur J Immunol 26: 759-767, 1996.
25. Giatromanolaki A, Koukourakis M, O'Byrne K, Whitehouse R, Gatter KC, Harris AL: Plasma cell macrophage infiltration and tumour neo-angiogenesis in non small cell lung cancer. In: "2nd International Lung Cancer Congress, Editor G.Antypas, Monduzzi Editore, Bologna, pp 107-111, 1996".
26. Anastassiou G, Duensing S, Steinhoff G, Zorn U, Grosse J, Dallmann I, Kirchner H, Ganser A, Atzpodien J: Platelet endothelial cell adhesion molecule 1 (PECAM-1): a potential prognostic marker involved in leukocyte infiltration of renal cell carcinoma. Oncology 53(2): 127-32, 1996.